Injuries to living tissue – cuts, lacerations, punctures – can cause physical pain and emotional distress to patients. Depending on the type and severity of the wound, they can have significant impact on sufferers’ overall quality of life.
Based on its proprietary technology platform, Klox Technologies is currently marketing and commercializing LumiHeal for the treatment of wounds, following the Q2 2017 release of its EUREKA data, in a pilot European country. Our goal is to provide healthcare professionals with an innovative, non-invasive, and cost-effective treatment alternative.
Additionally, we are furthering research and development of LumiHeal for the treatment of post-surgical scars and burns, as the factors that inhibit healing of these conditions are similar to those that impact the healing of chronic wounds.